Search research articles
Contact Us
Filters
Showing results (31-40 of 1,214) with videos related to
Page
of 122
Sort By:
The Journal of Clinical Psychiatry
|
July 3, 2009
Introduction: Balancing the equation: managing comorbidities in patients with severe mental illness
Roger S McIntyre
The Journal of Clinical Psychiatry
|
October 28, 2010
When should you move beyond first-line therapy for depression?
Roger S McIntyre
The Journal of Clinical Psychiatry
|
June 5, 2026
Prescribing GLP-1 Receptor Agonists for Persons With Mental Disorders: Evidence-Based and Aspirational Targets
Roger S McIntyre
The Journal of Clinical Psychiatry
|
March 14, 2019
Getting to Remission: Differentiating Residual Symptoms From Treatment Side Effects in Major Depressive Disorder
Roger S McIntyre
Expert Opinion on Pharmacotherapy
|
January 21, 2026
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have potential to transform health outcomes for persons with bipolar disorder, schizophrenia, Major depressive disorder and other serious mental illnesses by lengthening healthspan and reducing excess and premature mortality
Roger S McIntyre
Expert Opinion on Drug Safety
|
April 12, 2025
Does the use of generative AI chatbots by patients introduce risk of adverse drug events?
Roger S McIntyre
Expert Opinion on Investigational Drugs
|
June 18, 2025
Acetylcholine and muscarinic receptor targeting in bipolar disorder: does xanomeline-trospium chloride and other investigational muscarinic agonists hold promise as mechanistically informed treatments for manic episodes, mixed features and cognitive deficits in bipolar disorder?
Roger S McIntyre
Expert Opinion on Drug Safety
|
July 12, 2022
Rapid-acting antidepressants in psychiatry: episodic treatments, innovation, and clarion call for methodologic rigor in drug development
Roger S McIntyre
CNS Neuroscience & Therapeutics
|
October 19, 2010
Asenapine: a review of acute and extension phase data in bipolar disorder
Roger S McIntyre
Expert Opinion on Drug Safety
|
December 17, 2010
Transforming drug safety information
Roger S McIntyre
Page
of 122
Search research articles
Search
Showing results (31-40 of 1,214) with videos related to
Sort By:
Page
of 122
The Journal of Clinical Psychiatry
|
July 3, 2009
Introduction: Balancing the equation: managing comorbidities in patients with severe mental illness
Roger S McIntyre
The Journal of Clinical Psychiatry
|
October 28, 2010
When should you move beyond first-line therapy for depression?
Roger S McIntyre
The Journal of Clinical Psychiatry
|
June 5, 2026
Prescribing GLP-1 Receptor Agonists for Persons With Mental Disorders: Evidence-Based and Aspirational Targets
Roger S McIntyre
The Journal of Clinical Psychiatry
|
March 14, 2019
Getting to Remission: Differentiating Residual Symptoms From Treatment Side Effects in Major Depressive Disorder
Roger S McIntyre
Expert Opinion on Pharmacotherapy
|
January 21, 2026
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have potential to transform health outcomes for persons with bipolar disorder, schizophrenia, Major depressive disorder and other serious mental illnesses by lengthening healthspan and reducing excess and premature mortality
Roger S McIntyre
Expert Opinion on Drug Safety
|
April 12, 2025
Does the use of generative AI chatbots by patients introduce risk of adverse drug events?
Roger S McIntyre
Expert Opinion on Investigational Drugs
|
June 18, 2025
Acetylcholine and muscarinic receptor targeting in bipolar disorder: does xanomeline-trospium chloride and other investigational muscarinic agonists hold promise as mechanistically informed treatments for manic episodes, mixed features and cognitive deficits in bipolar disorder?
Roger S McIntyre
Expert Opinion on Drug Safety
|
July 12, 2022
Rapid-acting antidepressants in psychiatry: episodic treatments, innovation, and clarion call for methodologic rigor in drug development
Roger S McIntyre
CNS Neuroscience & Therapeutics
|
October 19, 2010
Asenapine: a review of acute and extension phase data in bipolar disorder
Roger S McIntyre
Expert Opinion on Drug Safety
|
December 17, 2010
Transforming drug safety information
Roger S McIntyre
Page
of 122